Investing in biologics excellence
pharmaphorum
MARCH 10, 2022
Driven by advancements in technology, these complex therapeutics have already made waves in life sciences, providing revolutionary treatment options in oncology, immune conditions and rare diseases. Biologics product development has increased steadily over the past decade, with the volume of business forecast to double by 2030.
98 
Let's personalize your content